| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 110.94B | 110.87B | 110.16B | 100.98B | 92.77B | 82.14B |
| Gross Profit | 14.67B | 12.96B | 14.08B | 10.18B | 9.00B | 10.20B |
| EBITDA | 9.42B | 8.00B | 8.81B | 4.97B | 4.10B | 5.32B |
| Net Income | 1.49B | 12.42B | 1.86B | 1.99B | 481.96M | 1.80B |
Balance Sheet | ||||||
| Total Assets | 139.52B | 154.91B | 142.91B | 153.57B | 107.12B | 104.55B |
| Cash, Cash Equivalents and Short-Term Investments | 20.63B | 32.27B | 21.67B | 21.13B | 10.02B | 7.88B |
| Total Debt | 24.19B | 23.86B | 24.12B | 24.06B | 11.56B | 6.98B |
| Total Liabilities | 59.33B | 62.67B | 61.86B | 61.18B | 38.55B | 33.13B |
| Stockholders Equity | 75.96B | 87.73B | 76.75B | 87.91B | 64.24B | 67.10B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.12B | 1.44B | -964.02M | -1.37B | -3.41B |
| Operating Cash Flow | 0.00 | 6.89B | 9.52B | 5.74B | 2.34B | 208.30M |
| Investing Cash Flow | 0.00 | 4.91B | -8.07B | -6.68B | -3.62B | -3.80B |
| Financing Cash Flow | 0.00 | -2.15B | -901.01M | 11.72B | 3.38B | -635.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥222.91B | 6.43 | 13.11% | 2.87% | 7.46% | 144.90% | |
75 Outperform | ¥214.74B | 14.77 | 7.50% | 5.39% | -1.82% | 23.07% | |
74 Outperform | ¥556.57B | 11.33 | ― | 2.60% | 1.02% | -2.46% | |
71 Outperform | ¥278.62B | -8.32 | ― | 1.93% | -1.60% | -71.42% | |
70 Outperform | ¥92.73B | 7.39 | ― | 1.61% | 0.65% | 569.87% | |
68 Neutral | ¥4.12B | -23.96 | ― | 4.39% | 5.81% | -22.23% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |